Triumph Capital Management’s abrdn Healthcare Investors HQH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1M Buy
45,512
+567
+1% +$11.2K 0.18% 123
2026
Q1
$800K Buy
44,945
+1,468
+3% +$27.8K 0.16% 133
2025
Q4
$823K Sell
43,477
-2,965
-6% -$56K 0.18% 118
2025
Q3
$857K Buy
46,442
+1,443
+3% +$23.6K 0.23% 97
2025
Q2
$697K Sell
44,999
-12,318
-21% -$191K 0.21% 118
2025
Q1
$931K Sell
57,317
-3,900
-6% -$67K 0.31% 75
2024
Q4
$983K Buy
61,217
+15,057
+33% +$267K 0.34% 65
2024
Q3
$859K Buy
+46,160
New +$860K 0.31% 78

Other funds holding HQH

Triumph Capital Management's HQH Position: Q2 2026 in Review

Triumph Capital Management increased its abrdn Healthcare Investors (HQH) stake by 1.3% in Q2 2026, buying an estimated $11.2K and bringing the position to 45,512 shares worth $1M. The position accounts for 0.18% of the portfolio, ranked #123.

Triumph Capital Management first reported a position in HQH in Q3 2024 and has held it in 8 quarters since. 126 funds tracked by Wall St. Rank hold HQH as of Q2 2026.

  • Triumph Capital Management held 45,512 shares of abrdn Healthcare Investors worth $1M as of Q2 2026.
  • Triumph Capital Management bought 567 abrdn Healthcare Investors shares in Q2 2026, an estimated $11.2K.
  • abrdn Healthcare Investors made up 0.18% of Triumph Capital Management's portfolio in Q2 2026, its #123 holding.
  • Triumph Capital Management first reported a position in abrdn Healthcare Investors in Q3 2024 and has held it in 8 quarters since.
  • 126 funds tracked by Wall St. Rank held abrdn Healthcare Investors as of Q2 2026.

Based on Triumph Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.